From 1016 opportunities to ΔG-visualization in the binding site

webinar

Thu, 26 Oct 2017, 14:00 CEST (Berlin)

Dr. Christian Lemmen, BioSolveIT GmbH, St. Augustin, Germany

From 1016 opportunities to ΔG-visualization in the binding site

Taking “the best of both worlds” is usually desirable but rarely achieveable in real life. In drug discovery it is worse: many solutions — so many choices — but no one software can handle all challenges equally well.
Workflow systems like KNIME® offer you a single interface to a myriad of tools and help you to organize, standardize, and streamline your approach and be best prepared all along the way from 1016 opportunities to visualizing atom-based ΔG-contributions in the binding site. We will show you a number of highly efficient strategies implemented this way. Plus you’ll get those as a blue print for your own solution.

Current news

category
Events
Boston Event: Expanding Molecular Diversity with CORE
September 15, 2026 17:27 CEST
Chemical Space Exploration Meets AI in Boston BioSolveIT and Onepot.AI invite you to an evening of science, drinks, and conversation at D16, the speakeasy beneath Dillon’s in Boston. Join us on September 30, 2026, for two very concise presentations exploring how ultra-large Chemical Spaces and artificial intelligence can open new...
Read on
category
Events
Beyond the Flatland: sp³-Rich Fragments Unlock Novel Kinase Chemotypes: Free Webinar!
September 15, 2026 10:40 CEST
Kinases are among the most intensively pursued target families in drug discovery, yet the chemical matter screened against them remains surprisingly narrow. Conventional kinase-focused libraries are dominated by flat, heteroaromatic compounds, while saturated, three-dimensional molecules stay largely underexplored. That narrow structural diversity makes it harder to find genuinely novel chemotypes,...
Read on
LifeCheMyriads by Life Chemicals - Access now with our tools
August 31, 2026 09:39 CEST
LifeCheMyriads brings an actionable, novelty-focused universe of 53 billion on-demand synthesizable compounds directly into your workflow. Created by Life Chemicals, this collection was built from 210 in-house-validated reaction protocols and 20,000+ proprietary and commercially available building blocks. The result is a medicinal chemistry-driven catalog spanning more than 340 million unique...
Read on